EGFR and cancer: EGFR or HER1 is a receptor tyrosine kinase that activates oncogenic signaling pathways including rat sarcoma virus (Ras)/MAPK, PI3K/Akt, and phospholipase C (PLC)/PKC, and drives cancer cell growth, survival, and invasion (Sigismund et al., 2018).